secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vericel Corp (VCEL)
CIK:        0000887359
Form:       8-K
Filed at:   2022-05-04T23:59:59+00:00
Accession:  0001628280-22-012148
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vericel Q1 revenue up 4% to $36.1M; net loss widens to $7.1M; reaffirms FY2022 guidance
--------------------------------------------------------------------------------

- Total net revenue $36.1M (+4% YoY); MACI $26.0M, Epicel $9.9M, NexoBrid $0.2M.
- Net loss $7.1M ($0.15/share) vs $3.3M loss a year ago; non-GAAP adj. EBITDA $3.2M.
- Reaffirmed FY2022 guidance: revenue $178-189M, gross margin ~70%, adj. EBITDA margin ~21%.
- MACI and Epicel biopsies growing double-digit; NexoBrid BLA resubmission on track for mid-2022.
- Appointed Mike Gilligan as VP, MACI National Sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/887359/000162828022012148/0001628280-22-012148-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/887359/000162828022012148/vcel-20220504.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-012148

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer